A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Active:	Yes
Cancer Type:	Lymphoma Non-Hodgkin Lymphoma	NCT ID:	NCT07226843
Trial Phases:	Phase I	Protocol IDs:	27804 (primary) NCI-2025-09711 2025-523601-16-00 J6Y-OX-JBFA
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	Eli Lilly and Company
NCI Full Details:	http://clinicaltrials.gov/show/NCT07226843

Summary

The main purpose of this study is to evaluate safety and efficacy, and measure how much
LY4584180 gets into the bloodstream and how long it takes the body to eliminate it in
patients with previously treated blood cancers. For each participant, the study could
last about 9 months or possibly longer including screening.

Treatment Sites in Georgia

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.